Immediate Impact

2 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Glioblastoma Therapy: Past, Present and Future
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
2 intermediate papers

Works of Ana Quintero being referenced

Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
2009
Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder
2006

Author Peers

Author Last Decade Papers Cites
Ana Quintero 156 230 7 172 15 507
Michael Hannemann 177 210 75 156 12 573
Soichiro Shizawa 125 149 1 167 10 451
Lloyd Rv 94 96 6 186 19 466
Tamar Eigler 250 70 9 211 12 519
Jing Zhang 122 78 37 97 19 490
Donald E. Fleenor 247 91 46 105 20 494
S Iorcansky 113 84 4 297 19 454
A. Fusco 338 137 30 199 17 563
Barbara Iwasiow 154 237 1 89 20 527
Ingela Ahlstedt 246 225 12 102 13 533

All Works

Loading papers...

Rankless by CCL
2026